Scholars Central

Research articlePublished Jun 2018

Differential Changes in Autonomic Functioning, Hypothalamic–Pituitary–Adrenal Axis Activity and Inflammation during Melatonergic Antidepressant Treatment between Depressed Patients with and without Suicidal Ideation

Authors: Chuan-Chia Chang, Nian-Sheng Tzeng, Yu-Chen Kao, Chin-Bin Yeh, Hsin-An Chang

Neuropsychiatry

Volume 8 · Issue 3 · Pages 820–832

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Abstract Objective: The existing literature has not yet simultaneously examined the modification of autonomic functioning, hypothalamic–pituitary–adrenal (HPA) axis activity and inflammation following agomelatine treatment of depression. We investigated the changes in the three biological systems that are closely linked to cardiovascular risks among depressed patients with/without suicidal ideation (SI) following agomelatine treatment. Methods Thirty-two unmedicated depressed patients with current SI (SI+ group) and 28 without current/lifetime SI (SI− group) completed 6-week agomelatine treatment. None of them had any current or lifetime suicidal behavior before entering the study. The peripheral levels of cortisol, erythrocyte sedimentation rate (ESR) and high sensitivity C-reactive protein (hs- CRP), and heart rate variability (HRV) were measured at baseline and week 6. The Hamilton Depression Rating Scale (HAM-D) and the Columbia Suicide Severity Rating Scale (C-SSRS) were assessed at baseline, week 2, 4 and 6. Results Between-group analyses showed a significant treatment-by-group interaction for cortisol, ESR, hs-CRP, the ratio of cortisol to hs-CRP (COR/CRP ratio), variance (total HRV), low frequency (LF)-HRV, and high frequency (HF)-HRV. The results were driven by decreases in cortisol, hs- CRP and ESR levels and increases in total HRV, LF-HRV and HF-HRV in the SI+ group, coupled with an increase in hs-CRP levels and a decrease in COR/CRP ratio in the SI− group. Moreover, in the SI+ group the lessening of the intensity of SI independently predicted the reduction in hs-CRP levels. Conclusions Agomelatine treatment differentially modified biomarkers of cardiac risk between depressed patients with current SI and those without SI. The specificity and underlying mechanism of melatonergic antidepressant beneficially affecting markers of cardiac risk in only depressed patients with current SI merits further investigation. Peripheral hs-CRP levels may serve as a potential tool to monitor the fluctuation of SI in depressed patients under agomelatine treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Neuropsychiatry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeuropsychiatry
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Chuan-Chia Chang”
  • BylineArticles whose byline prints “Nian-Sheng Tzeng”
  • BylineArticles whose byline prints “Yu-Chen Kao”
  • BylineArticles whose byline prints “Chin-Bin Yeh”
  • BylineArticles whose byline prints “Hsin-An Chang”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels